PaperdropDx


Paperdrop Diagnostics is a company developing rapid diagnostic tests based on paper microfluidics, aiming to make diagnostics accessible for all. Their flagship product, ResistgeneTM, addresses antimicrobial resistance by detecting multiple AMR genes. They focus on equipment-free, ultrasensitive, low-cost, fast, and easy-to-use tests, utilizing innovative nanotechnology and signal enhancement strategies. The company is a spin-off supported by various research institutions and funding programs, with a mission to provide affordable and effective diagnostic solutions for critical and prevalent diseases.

Industries

biotechnology
health-care
health-diagnostics
wellness

Nr. of Employees

small (1-50)

PaperdropDx

Belterra, Para, Brazil, South America


Products

Near-patient multiplexed paper-based assay for antimicrobial resistance genes

A paper-based, multiplexed assay intended for near-patient detection of multiple antimicrobial resistance genes with rapid visual readout and minimal equipment requirements.

Paper-based biomarker tests for drug-induced organ damage

Paper microfluidic assays designed to evaluate biomarkers indicative of drug-induced liver and kidney damage and systemic inflammatory state.


Services

Development and validation of paper-based rapid diagnostics

End-to-end development service from biomarker selection and bioreceptor implementation to MVP creation, analytical optimization, and clinical validation for paper-based diagnostic tests.

Expertise Areas

  • Paper microfluidics diagnostics
  • Point-of-care / near-patient testing
  • Biomarker discovery and panel design
  • Nanotechnology-enabled biosensing
  • Show More (4)

Key Technologies

  • Paper microfluidics
  • Lateral flow immunoassays
  • Nanoparticles and nanomaterials
  • Molecular and genetic biomarker detection
  • Show More (4)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.